CompletedNot Applicable

Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique

Mozambique520 participantsStarted 2004-03

Plain-language summary

To assess the influence of seasonal variations in Schistosoma haematobium transmission on treatment outcome (morbidity and re-infection)

Who can participate

Age range8 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * children aged 8-12 years Exclusion Criteria: * All children presenting with macro-haematuria or severe pathology detected by ultrasonography (large masses, pseudo-polyps or hydronephrosis/hydroureter) at the 6 months follow-up examination will be treated with praziquantel and excluded in the data analysis.

What they're measuring

cure rate

egg reduction rate

re-infection prevalence and intensity of infection *resolution of urinary tract pathology

re-appearance of pathology after re-infection.

Trial details

NCT IDNCT00231322

SponsorDBL -Institute for Health Research and Development

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Hematuria trials